SAN DIEGO (EGMN) – Postmenopausal women who took oral micronized progesterone for 12 weeks had significant improvements in vasomotor symptom scores as well as significant reductions in the number of daily vasomotor symptoms, results from a randomized, placebo-controlled trial showed.
